Young Joo Cha

Young Joo Cha

Auto-generated profile, based on publicly available information

Young Joo Cha

Corporate R&D Center for Biological Standards and Control, Resources and Innovation Cooperative, Hanam, Korea

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
YCYoung Joo Cha
Young Joo Cha
QPQuehn Park
Quehn Park
EKEun-Suk Kang
Eun-Suk Kang
BYByung Chul Yoo
Byung Chul Yoo
KPKyoung Un Park
Kyoung Un Park
MKMyung Hee Kim
Myung Hee Kim
Young Joo Cha, M.D., Quehn Park, M.D., Eun-Suk Kang, M.D., Byung Chul Yoo, M.D., Kyoung Un Park, M.D., Jin-Wook Kim, M.D., Yoo-Sung Hwang, M.D., and Myung Hee Kim, M.D.. Ann Lab Med 2013;33:184-9. https://doi.org/10.3343/alm.2013.33.3.184

1 January 2011 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
PDF file
JPJung-Chul Park
Jung-Chul Park
SCSeong-Ho Choi
Seong-Ho Choi
YKYong-Tae Kim
Yong-Tae Kim
SKSun-Jong Kim
Sun-Jong Kim
HKHee-Jung Kang
Hee-Jung Kang
YCYoung Joo Cha
Young Joo Cha
Park JC, et al. J Periodontal Implant Sci. 2011 Feb;41(1):3-9. http://dx.doi.org/10.5051/jpis.2011.41.1.3

1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
OKOh Seok Kim
Oh Seok Kim
SJSunghwan Ji
Sunghwan Ji
Heewon JungHeewon Jung
Heewon Jung
SMStephen Matthews
Stephen Matthews
YCYoung Joo Cha
Young Joo Cha
KKKeeWhan Kim
KeeWhan Kim
Kim OS, et al. J Korean Med Sci. 2024 May;39(20):e168. https://doi.org/10.3346/jkms.2024.39.e168

1 October 2007 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
HHHee Jin Huh
Hee Jin Huh
SCSeok-Lae Chae
Seok-Lae Chae
YCYoung Joo Cha
Young Joo Cha
The serological detection of the surface antigen (HBsAg) of hepatitis B virus (HBV) is the basis of detection of HBV infections in blood donors and patients with hepatitis. The aim of this study was to compare the performance of HBsAg enzyme-linked immunosorbent assay (ELISA) and HBsAg chemiluminescence immunoassay used in Korea. We compared seven assays: Architect i2000 (Abbott Laboratories, USA), Elecsys 2010 immunoanalyzer (Roche Diagnostics, Germany), Advia Centaur (Bayer Healthcare, USA), Murex HBsAg version 3 (Abbott Laboratories, USA), Enzygnost HBsAg 5.0 (DADE Behring, Germany), LG HBsAg ELISA (LG, Korea), and Genedia HBsAg ELISA 3.0 (Greencross Medical Science, Korea). We evaluated the sensitivity of each assay by testing serially diluted WHO HBsAg reference material, two seroconversion panels, and recombinant HBsAg with three mutations in the 'a' determinant. The lowest HBsAg level detected by each assay using WHO reference material was variable from 0.05 (Murex and Advia) to 0.2 IU/mL. When testing 21 seroconversion panels, the total number of positive samples was 15 by Murex and 14 by Architect. Murex, LG, and Architect detected all of the 3 mutant samples tested. Analytical sensitivity and mutant detecting ability among HBsAg commercial assays were variable and not related to the analytical methods, but related to the manufacturer's reagents. We suggest that each laboratory should select an HBsAg assay based on analytical performance, test throughput, and the applicability of full automation.

30 July 1993 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
HLHyo Rang Lee
Hyo Rang Lee
KHKi Soo Han
Ki Soo Han
BYByung Chul Yoo
Byung Chul Yoo
SPSill Moo Park
Sill Moo Park
YCYoung Joo Cha
Young Joo Cha
Helicobacter pylori is known to be a cause of active chronic gastritis and has been proposed as an etiologic factor in the development of peptic ulcer disease, but controversy continues regarding the pathogenic importance and mechanism. We examined the prevalence of H. pylori infection in patients with peptic ulcers and non-ulcer dyspepsia. 749 patients (373 with duodenal ulcer, 303 with gastric ulcer, 73 with non-ulcer dyspepsia) were included. Endoscopic mucosal biopsies were done at antrum, duodenum, and, if present, ulcer margin. The specimens were tested by Gram staining, Giemsa staining, culture, urease testing for identification of H. pylori. Antibody to H. pylori was examined in 83 patient of these patients by ELISA, and the result was compared with the results of bacteriologic studies. Prevalence of H. pylori in antral mucosa was higher in patients with duodenal ulcers (81.5%) than in patients with gastric ulcer and non-ulcer dyspepsia (56% and 52.8%) (P < 0.05). Also in the duodenal mucosa of non-ulcer sites, and the ulcer margin of patients with duodenal ulcers, the detection rates (12% and 40.7%) were higher than those in the duodenal mucosa of patients with gastric ulcer and non-ulcer dyspepsia (7% and 8%)(p < 0.005). Antibody to H. pylori was detected in all patients with duodenal and gastric ulcers and non-ulcer dyspepsia who were tested for antibody. In contrast, the detection rates of antibody in adult control and child control were 33.3% and 27%. Among patients with antibody to H. pylori, H. pylori was detected in 85.7% of patients with duodenal ulcer, 62.5% of patients with gastric ulcers and 22.2% of patients with non-ulcer dyspepsia (p < 0.05). These data suggest that H. pylori is a possible pathogen for duodenal ulcer by duodenal colonization probably via gastric metaplasia. Also the past or present infection of H. pylori in antral mucosa may play a role at least partially in generation of upper gastrointestinal symptoms.

1 April 2006 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
BPBo Rae G. Park
Bo Rae G. Park
YCYoung Joo Cha
Young Joo Cha
Park BR, et al. Korean J Lab Med. 2006 Apr;26(2):77-80. http://dx.doi.org/10.3343/kjlm.2006.26.2.77